These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 31465895)

  • 1. Ratio of plasma BDNF to leptin levels are associated with treatment response in major depressive disorder but not in panic disorder: A 12-week follow-up study.
    An JH; Jang EH; Kim AY; Fava M; Mischoulon D; Papakostas GI; Na EJ; Jang J; Yu HY; Hong JP; Jeon HJ
    J Affect Disord; 2019 Dec; 259():349-354. PubMed ID: 31465895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-treatment peripheral biomarkers associated with treatment response in panic symptoms in patients with major depressive disorder and panic disorder: A 12-week follow-up study.
    Kim K; Jang EH; Kim AY; Fava M; Mischoulon D; Papakostas GI; Kim H; Na EJ; Yu HY; Jeon HJ
    Compr Psychiatry; 2019 Nov; 95():152140. PubMed ID: 31669792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depression.
    Dreimüller N; Schlicht KF; Wagner S; Peetz D; Borysenko L; Hiemke C; Lieb K; Tadić A
    Neuropharmacology; 2012 Jan; 62(1):264-9. PubMed ID: 21803060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder.
    Smit AJT; Wu GWY; Rampersaud R; Reus VI; Wolkowitz OM; Mellon SH
    Psychoneuroendocrinology; 2024 Jul; 165():107045. PubMed ID: 38636352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electroconvulsive therapy (ECT) and aerobic exercise training (AET) increased plasma BDNF and ameliorated depressive symptoms in patients suffering from major depressive disorder.
    Salehi I; Hosseini SM; Haghighi M; Jahangard L; Bajoghli H; Gerber M; Pühse U; Holsboer-Trachsler E; Brand S
    J Psychiatr Res; 2016 May; 76():1-8. PubMed ID: 26859236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma brain-derived neurotrophic factor (pBDNF) and executive dysfunctions in patients with major depressive disorder.
    Wagner S; Kayser S; Engelmann J; Schlicht KF; Dreimüller N; Tüscher O; Müller-Dahlhaus F; Braus DF; Tadić A; Neyazi A; Frieling H; Lieb K
    World J Biol Psychiatry; 2019 Sep; 20(7):519-530. PubMed ID: 29334322
    [No Abstract]   [Full Text] [Related]  

  • 7. Correlations between brain-derived neurotrophic factor and clinical symptoms in medicated patients with major depression.
    Satomura E; Baba H; Nakano Y; Maeshima H; Suzuki T; Arai H
    J Affect Disord; 2011 Dec; 135(1-3):332-5. PubMed ID: 21774990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis.
    Polyakova M; Stuke K; Schuemberg K; Mueller K; Schoenknecht P; Schroeter ML
    J Affect Disord; 2015 Mar; 174():432-40. PubMed ID: 25553404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum ghrelin levels and the effects of antidepressants in major depressive disorder and panic disorder.
    Ishitobi Y; Kohno K; Kanehisa M; Inoue A; Imanaga J; Maruyama Y; Ninomiya T; Higuma H; Okamoto S; Tanaka Y; Tsuru J; Hanada H; Isogawa K; Akiyoshi J
    Neuropsychobiology; 2012; 66(3):185-92. PubMed ID: 22948519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum and plasma brain-derived neurotrophic factor and response in a randomized controlled trial of riluzole for treatment resistant depression.
    Wilkinson ST; Kiselycznyk C; Banasr M; Webler RD; Haile C; Mathew SJ
    J Affect Disord; 2018 Dec; 241():514-518. PubMed ID: 30153634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BDNF plasma levels variations in major depressed patients receiving duloxetine.
    Fornaro M; Escelsior A; Rocchi G; Conio B; Magioncalda P; Marozzi V; Presta A; Sterlini B; Contini P; Amore M; Fornaro P; Martino M
    Neurol Sci; 2015 May; 36(5):729-34. PubMed ID: 25501804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced serum BDNF levels are associated with the increased risk for developing MDD: a case-control study with or without antidepressant therapy.
    Emon MPZ; Das R; Nishuty NL; Shalahuddin Qusar MMA; Bhuiyan MA; Islam MR
    BMC Res Notes; 2020 Feb; 13(1):83. PubMed ID: 32085720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The changes of tPA/PAI-1 system are associated with the ratio of BDNF/proBDNF in major depressive disorder and SSRIs antidepressant treatment.
    Yang Z; Gao C; Li Z; Jiang T; Liang Y; Jiang T; Yu C; Yan S; Li P; Zhou L
    Neuroscience; 2024 Nov; 559():220-228. PubMed ID: 39244009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of last depressive episode may influence serum BDNF levels in remitted patients with major depression.
    Takebayashi N; Maeshima H; Baba H; Nakano Y; Satomura E; Kita Y; Namekawa Y; Nomoto H; Suzuki T; Arai H
    Depress Anxiety; 2012 Sep; 29(9):775-9. PubMed ID: 22447660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid stimulating hormone and serum, plasma, and platelet brain-derived neurotrophic factor during a 3-month follow-up in patients with major depressive disorder.
    Baek JH; Kang ES; Fava M; Mischoulon D; Nierenberg AA; Lee D; Heo JY; Jeon HJ
    J Affect Disord; 2014 Dec; 169():112-7. PubMed ID: 25189990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in miRNA-132 and miR-124 levels in non-treated and citalopram-treated patients with depression.
    Fang Y; Qiu Q; Zhang S; Sun L; Li G; Xiao S; Li X
    J Affect Disord; 2018 Feb; 227():745-751. PubMed ID: 29689690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline Plasma BDNF Levelsare Associated with Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Major Depressive Disorder.
    Zheng W; Gu L; Zhou Y; Wang C; Lan X; Zhang B; Li Z; Ning Y
    Curr Neuropharmacol; 2023; 21(4):1013-1021. PubMed ID: 36173064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain-derived neurotrophic factor levels and bipolar disorder in patients in their first depressive episode: 3-year prospective longitudinal study.
    Li Z; Zhang C; Fan J; Yuan C; Huang J; Chen J; Yi Z; Wang Z; Hong W; Wang Y; Lu W; Guan Y; Wu Z; Su Y; Cao L; Hu Y; Hao Y; Liu M; Yu S; Cui D; Xu L; Song Y; Fang Y
    Br J Psychiatry; 2014 Jul; 205(1):29-35. PubMed ID: 24764546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid antidepressant changes with sleep deprivation in major depressive disorder are associated with changes in vascular endothelial growth factor (VEGF): a pilot study.
    Ibrahim L; Duncan W; Luckenbaugh DA; Yuan P; Machado-Vieira R; Zarate CA
    Brain Res Bull; 2011 Aug; 86(1-2):129-33. PubMed ID: 21704134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants.
    Huang TL; Lee CT; Liu YL
    J Psychiatr Res; 2008 Jun; 42(7):521-5. PubMed ID: 17585940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.